Diagnosing STEMI in Patients with Left Ventricular Hypertrophy
Introduction to Diagnostic Challenges
- The European Society of Cardiology recommends that standard STEMI criteria (≥2 mm in V2-V3 for men ≥40 years, ≥1 mm in other leads) should not be directly applied to patients with LVH or LBBB, as these criteria were explicitly defined for patients without these conditions 1, 2
Diagnostic Approach
- The European Heart Journal suggests comparing ECGs with prior recordings, which is extremely valuable in LVH patients, to help identify secondary repolarization abnormalities that may vary over time without representing acute ischemia 3
- The European Heart Journal and Circulation recommend using concordant ST elevation (ST elevation in leads with positive QRS deflections) if LBBB is also present, to help diagnose STEMI in patients with LVH 1
- Circulation suggests looking for dynamic ST changes on serial ECGs during ongoing symptoms, as patients with true STEMI in the setting of LVH demonstrate greater magnitude of ST elevation and more leads with ST elevation 4
ECG Lead Placement and Interpretation
- The European Heart Journal and Circulation recommend recording right-sided leads (V3R, V4R) and posterior leads (V7-V9) for suspected inferior/posterior MI, as ST elevation ≥0.5 mm in V7-V9 confirms posterior MI even when anterior leads show only ST depression 1, 4, 5
Clinical Context and Decision Making
- The European Heart Journal recommends that prolonged chest pain (>20 minutes) not responding to nitroglycerin strongly supports acute MI regardless of ECG ambiguity, and point-of-care troponin at 1-2 hours can help decide on emergency angiography when ECG is equivocal 1
- The European Heart Journal and Circulation suggest that if clinical suspicion is high and proportional ST criteria are met, proceeding directly to emergency angiography without waiting for biomarkers is recommended 1, 2